by University of Michigan Many patients continue to struggle in the wake of the pandemic as they grapple with ongoing symptoms triggered by COVID-19 infection, a condition commonly known as long…[...]
Read More
Aurélie Fischer, Lu Zhang, Abir Elbéji, et. al.BMC Infectious Diseases volume 25, Article number: 603 (2025) Abstract Introduction Long COVID is a multisystemic, fluctuating condition inducing a high burden on affected people. Despite the existence of some guidelines,…[...]
Read More
Andrea Polli, Lode Godderis, Dries S. Martens, et. al., BMC Medicine volume 23, Article number: 60 (2025) Abstract Background Long-COVID is defined as the persistency or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with…[...]
Read More
Ana Flávia Avelar Maia Seixas, Milena Soriano Marcolino, Felipe Souza Guimarães, et. al.,, BMC Infectious Diseases volume 25, Article number: 509 (2025) Abstract Introduction Long COVID is a condition that occurs in patients with a previous history of…[...]
Read More
By Katie Camero, NBC News Why do some people develop disabling chronic conditions after the initial viral infection? The struggles of living with long Covid five years after the start of…[...]
Read More
Mabel Chan, PharmD, BCACP, Cardiology Advisors Myalgic encephomyelitis/chronic fatigue syndrome-like symptoms and upper respiratory symptoms in patients with long COVID were associated with not returning to a pre-COVID-19 state of…[...]
Read More
Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]
Read More
Five years after the pandemic hit, questions remain about how and why millions of Americans are still struggling with long-term disease. Michele G. Sullivan, Health Central According to a June 2024…[...]
Read More
The NIH-funded trial will determine if immunomodulation can improve brain and cardiovascular dysfunction. An immunomodulator being investigated by researchers at Vanderbilt University Medical Center holds promise in reversing the effects…[...]
Read More
Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al., Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025) Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There…[...]
Read More